Comprehensive Financial Planning Inc. PA Buys Shares of 252 Axon Enterprise, Inc. (NASDAQ:AXON)

Comprehensive Financial Planning Inc. PA purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, HoldingsChannel reports. The fund purchased 252 shares of the biotechnology company’s stock, valued at approximately $150,000.

Other institutional investors have also modified their holdings of the company. Sanctuary Advisors LLC purchased a new stake in Axon Enterprise during the second quarter valued at approximately $836,000. CWM LLC lifted its holdings in shares of Axon Enterprise by 1.3% during the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after purchasing an additional 36 shares during the last quarter. Wedmont Private Capital acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth $290,000. Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of Axon Enterprise by 322.6% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 393 shares of the biotechnology company’s stock worth $157,000 after purchasing an additional 300 shares in the last quarter. Finally, Perfromance Wealth Partners LLC purchased a new position in Axon Enterprise during the 3rd quarter worth $266,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 0.3 %

Shares of AXON stock opened at $679.24 on Monday. Axon Enterprise, Inc. has a twelve month low of $255.68 and a twelve month high of $698.67. The stock has a market cap of $51.79 billion, a P/E ratio of 175.51, a P/E/G ratio of 6.79 and a beta of 1.05. The stock has a 50 day moving average of $623.43 and a 200 day moving average of $496.32. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the sale, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This represents a 0.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock valued at $30,721,337 in the last 90 days. 6.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

AXON has been the subject of several recent analyst reports. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Finally, Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.